Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Press Release/Announcement

Relenza (zanamivir) inhalation powder.

Relenza (zanamivir) inhalation powder. MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; October 9, 2009.

Save
Print
March 12, 2010
MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; October 9, 2009.

This alert notifies health care providers of the potential for patient harm if a particular inhalation powder is reconstituted and incorrectly administered.

Save
Print
Cite
Citation

Relenza (zanamivir) inhalation powder. MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; October 9, 2009.